Innovotech

What Innovotech does

Innovotech Inc. is a publicly traded Canadian contract research organization (CRO) headquartered in Edmonton, Alberta, listed on the TSX Venture Exchange (IOT.V) and OTCQB (IOTCF). The company operates through its wholly-owned subsidiary Innovotech Labs Corporation, a GMP- and ISO/IEC 17025-accredited laboratory specializing in antimicrobial and biofilm testing services. Its core proprietary technology is the MBEC Assay® — a high-throughput 96-well biofilm inoculator (corresponding to ASTM E2799) available in multiple configurations and with substrate coatings (silicone, cellulose, hydroxyapatite, titanium dioxide) — together with the proprietary BEST Assay™ and BESTplus Assay® methods for customized biofilm eradication and surface testing. The laboratory also holds a Drug Establishment License and operates a Containment Level 2 facility with a library of approximately 3,000 microbial strains, and recently added MALDI-TOF MS capability for rapid organism identification.

The company generates revenue through two primary streams: fee-for-service contract research and testing (compendial microbiology, antimicrobial susceptibility testing per CLSI methods, GMP analytical chemistry using HPLC, GC, GC/MSD, FTIR, UV-Vis, and TOC instrumentation, medical device antimicrobial testing, stability and method development) sold directly to enterprise customers; and product sales of MBEC Assay® kits and InnovoSIL™ Silver antimicrobial silver through its e-commerce storefront, with kit pricing ranging from approximately USD $305 to USD $3,678 per unit depending on configuration. Customer segments are diversified across pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical industries, with pharmaceutical and medical device manufacturers identified as primary verticals. End customers include companies requiring 510K and other regulatory submission support, USP and Ph.Eur compendial compliance, and high-throughput biofilm testing under physiologically relevant conditions.

Innovotech has been operating for 25+ years and maintains a small employee base of 11-50 staff concentrated at its Edmonton facilities (a head office at Suite C203, 2011-94 Street and a GMP lab at 9407 20 Ave NW). The company supplements operational funding with periodic non-dilutive Canadian government grants, most recently a CAD $234,000 NRC IRAP award in May 2026 to develop new medical device antimicrobial testing methods aligned with international regulatory changes. The company is led by CEO Craig Milne and presents regularly at retail-investor forums; its TSX-Venture-listed stock trades at CAD $0.10, consistent with a small-cap specialized CRO rather than a scaled testing platform.

Name

Innovotech

Legal name

Innovotech Inc.

Website

https://innovotech.ca

Company type

Public

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Short description

Innovotech is a publicly traded Canadian contract research laboratory providing GMP- and ISO-accredited antimicrobial and biofilm testing services, plus proprietary MBEC Assay® kits and InnovoSIL™ Silver, to pharmaceutical, medical device, biotech, compounding pharmacy, and nutraceutical clients.

Ownership category

akta.pro rank

Product category

Contract Research & Antimicrobial Testing Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Microbiology & Infectious Disease Testing (Trial Support) (HLAGAEAF)

Keywords

• Antimicrobial testing services
• Biofilm assay products
• Contract research laboratory
• Medical device testing
• GMP analytical chemistry

Headquarters

HQ city

Edmonton

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Contract Research Services: Fee-for-service antimicrobial, biofilm, microbiology, and analytical chemistry contract research and testing services for pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical clients. Services include compendial testing, method development and validation, stability testing, and GMP analytics.
2. MBEC Assay® Product Sales: Sale of proprietary MBEC Assay® biofilm inoculator kits in multiple formats (96-well base, trough base) with various coatings (uncoated, silicone, cellulose, hydroxyapatite, titanium dioxide). Sold directly via e-commerce storefront.
3. InnovoSIL™ Silver Product Sales: Sale of InnovoSIL™ Silver antimicrobial silver-based product.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Innovotech is a GMP- and ISO/IEC 17025-accredited contract research laboratory that provides antimicrobial and biofilm testing services to pharmaceutical, biotechnology, medical device, compounding pharmacy, and nutraceutical clients. The company also manufactures and sells its proprietary MBEC Assay® biofilm inoculator kits and InnovoSIL™ Silver antimicrobial product directly through its e-commerce storefront.

Product overview

Innovotech provides a portfolio of laboratory testing services and proprietary testing products for antimicrobial and biofilm research. The core product line includes the MBEC Assay® system ( biofilm inoculator kits with 96-well and trough base formats) available with various surface coatings (silicone, cellulose, hydroxyapatite, titanium dioxide) for testing on different substrate materials. Supporting the assay products, Innovotech offers comprehensive contract research services including microbiology testing, antimicrobial susceptibility testing (MIC/MBC/MFC), medical device testing, and GMP analytical chemistry services. The company also markets InnovoSIL™ Silver as an antimicrobial agent product. Together, these products and services enable clients in pharmaceutical, biotechnology, medical device, and nutraceutical industries to evaluate antimicrobial efficacy, achieve regulatory compliance, and bring products to market.

Differentiator

Problem solved

Functional benefit

Brands

• MBEC Assay®: High-throughput biofilm inoculator assay used to determine the efficacy of antimicrobials against biofilms. Available in various configurations including 96 well base and trough base, with optional coatings such as silicone, titanium dioxide, hydroxyapatite, and cellulose.
• BEST Assay™
• InnovoSIL™ Silver

Products and services

• MBEC Assay® Biofilm Inoculator with 96 Well Base
• MBEC Assay® Biofilm Inoculator with Trough Base
• MBEC Assay® Coated Peg Variants
• InnovoSIL™ Silver
• Microbiology Testing Services
• MIC, MBC, MFC, and Toxicology Testing Services
• Medical Device Testing Services
• GMP Analytical Chemistry Testing Services
• BEST Assay™ Method Testing Service

Quantifiable outcome

• Assisted clients in achieving 510K regulatory approvals and other product regulatory submissions
• +1 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Nelson Laboratories: Specialized medical device testing laboratory offering antimicrobial, biocompatibility, and sterilization testing. Directly comparable to Innovotech's medical device antimicrobial testing services for FDA 510(k) submissions.
• bioMérieux: Specialist in in vitro diagnostics and industrial microbiology, including antimicrobial susceptibility testing and microbial identification (e.g., VITEK, MALDI-TOF BioTyper). Most directly comparable peer to Innovotech's antimicrobial testing and recent MALDI-TOF capability.
• Microbiologics: Producer of microbial reference strains and quality control organisms used by labs performing antimicrobial and diagnostic testing. Comparable to Innovotech's ~3,000-strain microbial collection and CL2 laboratory capabilities.
• ATCC (American Type Culture Collection): Global biological resource center providing authenticated microbial strains and reference materials to researchers and industry. Comparable to Innovotech's microbial strain collection and the strain-based testing services built around it.

Broad incumbents

• SGS: Global testing, inspection, and certification company with a life sciences microbiology and analytical chemistry practice serving pharma and medical device clients. Overlaps with Innovotech's GMP analytical chemistry and microbiology service lines.
• Becton, Dickinson and Company (BD): Major medical device and diagnostics company with microbiology and antimicrobial testing product lines (e.g., BD MAX, BD Phoenix). Serves many of the same pharma and clinical lab customers as Innovotech with broader scale and product portfolio.
• Intertek: Global TIC provider with pharmaceutical and medical device testing services including antimicrobial and biocompatibility testing. Comparable to Innovotech in serving medical device manufacturers with regulated testing workflows.
• Charles River Laboratories: Global CRO offering endotoxin, microbial detection, and antimicrobial/biological testing services to pharma and medical device manufacturers. Overlaps with Innovotech's GMP contract microbiology services but at much larger scale and broader scope.
• Eurofins Scientific: International testing laboratory group with extensive microbiology and antimicrobial testing capabilities for pharma, medical device, and consumer products. Competes with Innovotech's contract research and compendial microbiology services across multiple geographies.

Emerging players

• Accelerate Diagnostics: Specializes in rapid antimicrobial susceptibility testing and identification of pathogens, including biofilm-related infections. Comparable technology overlap with Innovotech's antimicrobial and biofilm susceptibility testing focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/innovotech-inc-
• Xx.com/innovotech
• Facebookfacebook.com/Innovotech

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Innovotech